neoGMP^®

Fast Track To Personalized Therapy

neoGMP^® Service

neoGMP^® produces unique plasmid DNA for each patient at a small scale, compared to a single, large-scale lot for many patients. The service supports the requirements for rapid production from a patient-specific sequence while maintaining the high quality you expect from Aldevron.

Plasmid DNA in Neoantigen Therapy-2

Features of neoGMP^®

Rapid turnaround
Single-use, product-dedicated materials and equipment
Options for parallel processing
Quality oversight of key processes and parameters
Segregated manufacturing

► Download the neoGMP Service Flyer

Aldevron Advantage

22+ year track record in DNA manufacturing
Regulatory experience
Process optimization expertise
Investments in manufacturing process development

neoGMP^® Resources

GMP-S Gene Synthesis

ALD-Neo-Gene-Synthesis

Designed to meet the needs of rapid clinical gene synthesis for novel cancer treatments based on neoantigens.

Learn more about our GMP-Source^® Gene Synthesis Service.

Press Release

ALD-NeoGMP-Data

Aldevron has experience bringing neoantigen vaccines to the commercial market.

Learn more about our collaboration with Ziopharm Oncology.

Connect with an Expert

ALD-Connect-Expert

Connect with us to learn more about how our neoGMP^®service can be customized to fit your specific neoantigen projects.

Connect with one of our neoGMP experts to discuss your project.